Page last updated: 2024-08-24

imiquimod and Hemangioendothelioma

imiquimod has been researched along with Hemangioendothelioma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ishiuji, Y; Nakagawa, H; Nobeyama, Y	1
Gugneja, S; Miller, R; Neuschler, E; Neuschler, N; Paller, AS; Puscasiu, E; Sidbury, R; Sun, P; Tomai, M; Wang, XQ	1

Reviews

1 review(s) available for imiquimod and Hemangioendothelioma

Article	Year
Retiform hemangioendothelioma treated with conservative therapy: report of a case and review of the literature. International journal of dermatology, 2016, Volume: 55, Issue:2 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Glucocorticoids; Hemangioendothelioma; Humans; Imiquimod; Injections, Intralesional; Lasers, Dye; Male; Nose Neoplasms; Skin Neoplasms; Triamcinolone Acetonide	2016

Article

Year

Retiform hemangioendothelioma treated with conservative therapy: report of a case and review of the literature.

International journal of dermatology, 2016, Volume: 55, Issue:2

Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Glucocorticoids; Hemangioendothelioma; Humans; Imiquimod; Injections, Intralesional; Lasers, Dye; Male; Nose Neoplasms; Skin Neoplasms; Triamcinolone Acetonide

2016

Other Studies

1 other study(ies) available for imiquimod and Hemangioendothelioma

Article	Year
Topically applied imiquimod inhibits vascular tumor growth in vivo. The Journal of investigative dermatology, 2003, Volume: 121, Issue:5 Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Apoptosis; Female; Hemangioendothelioma; Imiquimod; Matrix Metalloproteinase 9; Mice; Proliferating Cell Nuclear Antigen; Tissue Inhibitor of Metalloproteinase-1	2003